April 3, 2023
SciCross has been awarded a grant from VINNOVA, with support from Medtech4Heath and Swelife, for the development of a novel way to treat ANCA vasculitis (an autoimmune blood vessel disease).…
June 28, 2022
In collaboration with UCL, Charles University in Prague and the Karolinska Institute we have a poster at ISMB 2022 (Madison US) with the title "Using Metabolomic and Transcriptomic profiles to…
April 4, 2022
See pubmed for detail, https://pubmed.ncbi.nlm.nih.gov/35349756/.
October 30, 2021
Together with scientist from UCL, we have written a review article covering AI technologies in the field of chronic inflammatory disease. Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated…
September 30, 2021
Check out the latest Covid-19 related publications. SciCross main contributions in these projects has been the design of Sars-CoV-2 peptides used to study T-cell responses. An evaluation of a FluoroSpot…
October 2, 2020
In a collaboration with Novartis, we (SciCross) has developed a method for improved HLA class II binding prediction based on MAPPs data. The results till be presented at the Immunogenicity…
August 18, 2020
New paper published in Lancet Rheumatology on immune cell signatures in JSLE patients, discovered by machine learning techniques AND extensive laboratory work AND clinical knowledge. Really happy to have the…
May 7, 2020
SciCross partners with scientists from Uppsala University, KTH and SciLifeLab in developing Covid-19 treatments in immune suppressed individuals. The project is called “An adaptable therapeutic technology platform to treat SARS-CoV…